Stockreport

Innovate Biopharmaceuticals’ Dose Response Data for Larazotide Acetate Demonstrating Its Unique Mechanism of Action and Applications in Diseases Caused by Increased Intestinal Permeability

MONSTER DIGITAL  (MSDI) 
PDF RALEIGH, N.C., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”), a clinical stage biotechnology company focused on developing novel med [Read more]